Private equity sponsors run technical due diligence like financial due diligence: find the exposure, size it, put it in the model. Then the technical report comes back as a list of Jira-shaped findings sorted by severity, and nobody on the investment committee can do anything with it.
That mismatch is the single most common failure mode I see in PE-backed technical diligence, and it's fixable with one discipline: price everything in dollars and calendar time, never in ticket counts or severity labels. (For what to inspect in the first place, the technical due diligence checklist covers it section by section.)
Why severity labels don't survive the IC meeting
"High," "medium," "low" are engineering vocabulary. They tell a developer where to start. They tell an investment committee nothing, because severity has no unit the deal team can put next to EBITDA, hold period, or purchase price adjustment.
A partner reading "fourteen high-severity findings in the authentication layer" has no way to compare that against "the add-on acquisition needs SSO and SCIM in nine months to close the enterprise pipeline." One is a count. The other is a business requirement with a deadline. They don't share units, so the finding gets noted, filed, and ignored until it blows up post-close, usually right when the platform is supposed to absorb the next acquisition.
Price technical debt the way you'd price any other deal risk
Every other diligence workstream in a PE deal gets priced. Legal exposure gets a dollar range and a probability. Customer concentration gets modeled against retention. Technical debt is the one workstream that routinely ships without a number, and it's the one workstream most likely to break the thesis, because most PE theses depend on the platform scaling or bolting on acquisitions, and debt is exactly what blocks scaling and integration.
The fix is a simple reframe: don't report "this needs to be fixed." Report "this costs an estimated amount and a timeframe to fix before you can do the thing the thesis depends on." A sponsor can act on a priced constraint. They can build it into the model, push it into the purchase price negotiation, or stage it into the first 100-day plan. They cannot act on a backlog.
What a priced finding looks like
A priced technical debt item has four parts, not two:
- The constraint. What the system currently cannot do, stated as a business capability gap, not a code smell. Not "the auth service is a monolith" but "the platform cannot support a second brand or a white-label partner without a rewrite of the tenant model."
- The trigger. What the sponsor's plan does that collides with the constraint. Usually it's the next acquisition, a new enterprise logo requiring SOC 2, or a geographic expansion that trips a data residency requirement.
- The cost estimate, with its basis stated. Not a bare number. "Roughly six to nine months of two senior engineers plus a migration window" is a defensible estimate. State the basis (team size, duration, complexity comparable) so the sponsor can sanity check it rather than take it on faith.
- The sequencing option. Fix it before close (escrow or purchase price adjustment), fix it in the first 100 days (budget it into the operating plan), or accept it as a known constraint on the thesis (push out the add-on timeline). All three are legitimate. Silence is not.
Where this shows up in PE-backed portfolios specifically
Sponsors running a buy-and-build strategy hit this constantly (it is most of what PE firms use fractional CTOs for across a portfolio), because the thesis is explicitly "we will bolt on three to five acquisitions onto this platform." Every acquisition is a stress test of the original platform's extensibility, and every piece of unpriced debt in the original platform becomes a surprise at the worst possible time, mid-integration, with a seller's team already gone and a new company's data waiting to migrate.
The portfolio companies that handle this well treat technical debt the same way they treat a contract renewal date: tracked, dated, and owned by someone with budget authority. The ones that don't treat it as engineering housekeeping find out it's a capital allocation problem the week the second add-on's data model doesn't fit.
What to ask for if you're the sponsor
If you're running diligence on a platform company or evaluating a fractional CTO's findings post-close, ask for three things explicitly, before you accept the report:
- A dollar-and-timeline estimate on every finding rated high enough to block a thesis-critical capability, not just a severity tag.
- The trigger stated: which of the sponsor's own 12-24 month plans does this finding collide with.
- A sequencing recommendation: before close, first 100 days, or accepted risk. Not a list with no owner and no date.
Need help thinking this through? Book a 30-min call — no pitch. Book a Free 30-Min Strategy Call →


